{"name":"Latigo Biotherapeutics","slug":"latigo-biotherapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQWWl1by12WlJ1bHk1SDd3azJEOUhfX0szbldiUDNWUWs4TWZKak1Fc3VFeWJzRXlsUFhmRFNlMjE2UTlPLXN0QWJJTFpVa3Z4NnBVTUtkdHVjSWhfS3hsc01aUmVWcjJManJaem1ueFlsQlphZFBMTFVGbWNtYVRjTGtEeXplSWg1MnJpSmVPWFVrTDhaMlo0?oc=5","date":"2026-03-04","type":"pipeline","source":"The Pharma Letter","summary":"Latigo appoints Neha Krishnamohan as CFO and CBO - The Pharma Letter","headline":"Latigo appoints Neha Krishnamohan as CFO and CBO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNTjJlUEZkb1Y2REVOQkd0SFEzdUo4YV9EVzBzNEw3YnludTRiRndVN0tJS0F4ekM2RlllcUhTWWY3cWdfMXRZN1pqeDlnQWIxMzdiTE1mZnZqcno3SFQ5U3R5R3AyQ1hCZmZ6emQ0ZS1KTkFqTi1nbHJlNGdJWVZCeUx6RUtUWFJSZVRkSVdsTFR1cG5MdG5SLUVOa3VZX21wbU4xNGdRRQ?oc=5","date":"2026-03-03","type":"pipeline","source":"Contract Pharma","summary":"Latigo Biotherapeutics Names Neha Krishnamohan CFO and CBO - Contract Pharma","headline":"Latigo Biotherapeutics Names Neha Krishnamohan CFO and CBO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPQWhsM1JXd09IdVFIWTVmMkRZVklrOG4xU1BZQTRUMTJjOXlVX1lvVFVuWi1pTTl2Qi1vdGJqMExwVEFBWk9pSEFXWHNUTUpXaDIyck01enU2RkR0bExLUUZ3bkJ6eldCXzJJekZ2UHVzU2ZBak1rVmtUNlRrSTY1Uk9OMV9GYnRPc0RNNUQ3eFRDdmpwWDRhU282QTNWNnltZy1tVzNTREVXSEc1amZZQjBTVm1GWnl4a2dQY1BvUkZyWkxZR1hIbUpkM2U3VnJS?oc=5","date":"2025-04-19","type":"pipeline","source":"The Pharma Letter","summary":"Latigo’s $150 million fundraise shows potential gains from pain as early-stage non-opioid pipeline grows - The Pharma Letter","headline":"Latigo’s $150 million fundraise shows potential gains from pain as early-stage non-opioid pipeline grows","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQWVpJM19YQlJKR2FfTDFjZlc4UlY3eVZJUm1hM2dzX1h0eDRJUk1TZUpVMDZnZ1I2eTdqdl9nRktKM1JLWlNpMTFZY2VrcjE5R2R2bDBPT0V4VVVva2l4dVpYVndHN2duWHFNUEQ3NFVoTjVxNHFhWDJ4WkdWNm5VZkNJdm5iaEJxUGVGdEhwVU9JX3JpUlRjZWxWalg2S29pT01jai01SE12M3hG?oc=5","date":"2025-03-24","type":"pipeline","source":"PharmTech.com","summary":"Latigo Biotherapeutics Raises $150 Million to Advance Non-Opioid Pain Therapeutics - PharmTech.com","headline":"Latigo Biotherapeutics Raises $150 Million to Advance Non-Opioid Pain Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxQMEc0VHRTTEZJTEVESDJ5RllCWExxbExqTVhYWmh1aU5qTlg0NVFqUkxRbFdsYVZUMlFEQnFTLU9WNGFuamU1OEwxellveXJFX1lMUXh2UFBhUU9sMmFaUm05ck1icmFKM2dVcU5aX3pheEdfN0R3UmVhSFRVQUlLaHpaQWZmbkNYRVNvTG9UYUJieko1WWRodlpSOFYyZDRLSzR5M1pULTNkVkVPUzQ3QU9UelMyVDNwRDRBNkd0VTd1R1ctME1PcENaWVVjbTJ0bGkwS285OFpDR0JGbjRWYWlDQUs1NFlUdVloQ2pDZHg?oc=5","date":"2025-03-17","type":"pipeline","source":"prnewswire.com","summary":"Latigo Biotherapeutics Closes $150 Million in Series B Financing to Advance Non-Opioid Pain Therapeutics - prnewswire.com","headline":"Latigo Biotherapeutics Closes $150 Million in Series B Financing to Advance Non-Opioid Pain Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOTGJfN0xfOHVaRjZTWDA3c2N2Ymw5NDlVZ1pYNjdBeXdZUXhkc3pZME9vODJxZE9yM2VtaEJsS2UxSU5MN0hfTHYxb2RFMjJHeVdNV2lMRkhfYUpOVUx4X3RqYmxFUmxtaDZSRnlhM3Y1Q1otSjdhY1hyVDI4M0tsN1Bielk?oc=5","date":"2025-03-17","type":"pipeline","source":"BioPharma Dive","summary":"Latigo raises $150M to get non-opioid pain drugs through key tests - BioPharma Dive","headline":"Latigo raises $150M to get non-opioid pain drugs through key tests","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNMjFKSFcyaW96TFQ2SGNvUmRvampUeWE4UFhPWS1yQkZsX2w4cGg0cUNwTy03WGxBV05LdVpOMlhiYzNJWVc5VUxDTkgweE5QY0hlOGg2TEltSnkwYXRlX2FtbzBhYnk0NUI5dmJVZGNGOFJ1aXlsNmtkblVZZEpLZklld29pdUsxVWM4TkNCSWRmX3Vhd21PQTVVbHBKZERLbmJXaU9IME8yVU9F?oc=5","date":"2025-03-17","type":"pipeline","source":"Fierce Biotech","summary":"Latigo saddles up with $150M to spur non-opioid pain drugs through the clinic - Fierce Biotech","headline":"Latigo saddles up with $150M to spur non-opioid pain drugs through the clinic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9POEhhZDY2Y2Exb0YtSmlKcHV2Rnl0MzNnUUZNV19HTzFlc0VIWHptMExVQWFjRzNWaTl1alFfTUZTWTIyaFBzZ2IzWEpGcjlpOTJj?oc=5","date":"2025-03-17","type":"pipeline","source":"FirstWord Pharma","summary":"Riding non-opioid hype wave, Latigo pockets $150M to push pain portfolio forward - FirstWord Pharma","headline":"Riding non-opioid hype wave, Latigo pockets $150M to push pain portfolio forward","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNYXZRVjJsUTJXMnV1NzI5cC1VWnFPZUVsOV80d1hXckdRb2FUZlJhd1RZdVhYZEcxWGFrLVV0QkM0LTBtWjJRUXZNU0NQdXRsNlNxRGZlY3F3VWg5QWM2OG5sWmxnN3FRN2tYN3Z3NnNWUXJ5ZUt2WjNCQ0NLcVVSVQ?oc=5","date":"2025-03-17","type":"pipeline","source":"pharmaphorum","summary":"Latigo raises $150m for non-opioid painkiller push - pharmaphorum","headline":"Latigo raises $150m for non-opioid painkiller push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOMEhoakZpMHlVb3RyQmFfTlRuOFN4bmxJbHRNTW53MHZGOTdocFRpMnRMLXYyc0wyUmRxb2lRbjByQnp0N3JDNGtUdVVscG0zeFlkOFNUNllIMVF1MFhZZlJIZy1laUhYb1p5YUhBTVBKOVl3V01CYnZreURsV2kxcEdDc3UtU2JFRWc?oc=5","date":"2024-07-22","type":"pipeline","source":"Contract Pharma","summary":"Latigo Biotherapeutics Names New CEO - Contract Pharma","headline":"Latigo Biotherapeutics Names New CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxONUVmMGg2M0ptUzdKRDcyQzMwX3NkOWhyS1Fub0REQVNUSDNCdUNLVmViN25LU2tXNGZFQTloUmlQSW1ra19nWHlWS1ZSNzR1bTFaUll6eF9rdFg1NEstUGMtLTdqRTRZeE5ncENtZk9VdTk1NUludWMtUElfY05mVUVrWEltNUY2ZXJwM0FyT29ZWXV0bzBoRDNaM29XUUpL?oc=5","date":"2024-02-14","type":"pipeline","source":"Fierce Biotech","summary":"Latigo, running behind Vertex in non-opioid pain race, raises $135M to catch up - Fierce Biotech","headline":"Latigo, running behind Vertex in non-opioid pain race, raises $135M to catch up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPVm0tSjVGMUg1eEZYdFZOSElVdFVtNWU3Y01uOHhLbXNDNFg4MnFIYVJIUDBWR3p1VU0tREpOU1NYc2wxaWVZSDN5RE1VdDg3alZOSnRqWjZnVnBkXzA4LWZHaWw1TlhyUjMxc2JHdTM3NGJPM0JHNTIwZlFCMHFfM3phZkNxZUJIX0l4U1B0UHlHTmpYWmRfVHJaNlFvX1R1SzBDQg?oc=5","date":"2024-02-13","type":"pipeline","source":"BioSpace","summary":"Latigo Launches into Non-Opioid Pain Medicine Space with $135 Million Series A - BioSpace","headline":"Latigo Launches into Non-Opioid Pain Medicine Space with $135 Million Series A","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}